European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice

Summary The present guideline summarizes all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contact dermatitis Ročník 73; číslo 4; s. 195 - 221
Hlavní autoři: Johansen, Jeanne D., Aalto-Korte, Kristiina, Agner, Tove, Andersen, Klaus E., Bircher, Andreas, Bruze, Magnus, Cannavó, Alicia, Giménez-Arnau, Ana, Gonçalo, Margarida, Goossens, An, John, Swen M., Lidén, Carola, Lindberg, Magnus, Mahler, Vera, Matura, Mihály, Rustemeyer, Thomas, Serup, Jørgen, Spiewak, Radoslaw, Thyssen, Jacob P., Vigan, Martine, White, Ian R., Wilkinson, Mark, Uter, Wolfgang
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford, UK Blackwell Publishing Ltd 01.10.2015
Wiley Subscription Services, Inc
Témata:
ISSN:0105-1873, 1600-0536, 1600-0536
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Summary The present guideline summarizes all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions and discussions of different pertinent topics are followed by a highlighted short practical recommendation. Topics comprise, after an introduction with important definitions, materials, technique, modifications of epicutaneous testing, individual factors influencing the patch test outcome or necessitating special considerations, children, patients with occupational contact dermatitis and drug eruptions as special groups, patch testing of materials brought in by the patient, adverse effects of patch testing, and the final evaluation and patient counselling based on this judgement. Finally, short reference is made to aspects of (continuing) medical education and to electronic collection of data for epidemiological surveillance.
Bibliografie:Uriach Pharma
ArticleID:COD12432
GlaxoSmithKline
Appendix S1. Professional training in cutaneous allergy.
Unilever
Intendis - Bayer
istex:81A23000794346CF037C1F084481DC9181E4B61B
Novartis
l'ARCAA
ark:/67375/WNG-BBKPTG3R-M
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
ISSN:0105-1873
1600-0536
1600-0536
DOI:10.1111/cod.12432